Full Text View
Tabular View
Study Results
Related Studies
A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age
This study has been completed.
Study NCT00834041   Information provided by Novartis

First Received on January 30, 2009.   Last Updated on April 15, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial